COVID-19 vax 'potential trigger' for exacerbation of idiopathic pulmonary fibrosis
Italian researchers have detailed four cases temporally linked to mRNA vaccination
The immune response induced by COVID-19 vaccination could trigger acute exacerbations and death in patients with idiopathic pulmonary fibrosis, clinicians have warned.
Although documented cases have been rare to date, Italian researchers say adults with the chronic lung disease require close monitoring after receiving a COVID-19 vaccine to detect worsening of symptoms or oxygen desaturation.
But they stressed that inoculation against SARS-CoV-2 was still strongly advised in the idiopathic pulmonary fibrosis (IPF)
